Description
SARS-CoV-2-IN-14 (compound 6) is a potent inhibitor of SARS-CoV-2 with anIC5o of 0.39 uM. SARS-CoV-2-IN-14 is a niclosamide analogue. SARS-CoV-2-IN-14 contains higher stability in human plasma and liver S9 enzymes assay than niclosamide. which can improve bioavailability and half-life when administered orally[1.
Product information
CAS Number: 22203-98-1
Molecular Weight: 282.12
Formula: C13H9Cl2NO2
Chemical Name: 5-chloro-N-(3-chlorophenyl)-2-hydroxybenzamide
Smiles: OC1=CC=C(Cl)C=C1C(=O)NC1=CC(Cl)=CC=C1
InChiKey: NXDGLRGDIKDWIF-UHFFFAOYSA-N
InChi: InChI=1S/C13H9Cl2NO2/c14-8-2-1-3-10(6-8)16-13(18)11-7-9(15)4-5-12(11)17/h1-7,17H,(H,16,18)
Technical Data
Appearance: Solid Power
Purity: ≥98% (or refer to the Certificate of Analysis)
Solubility: To be determined
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis
Storage Condition: Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.
Shelf Life: ≥12 months if stored properly.
Stock Solution Storage: 0 - 4 oC for 1 month or refer to the Certificate of Analysis.
Drug Formulation: To be determined
HS Tariff Code: 382200
Products are for research use only. Not for human use.
Payment & Security
Your payment information is processed securely. We do not store credit card details nor have access to your credit card information.
